Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 04/29 09:59:57 pm
84.68 USD   -0.49%
04/28 BIOMARIN PHARMA : reports 1Q loss
04/28 BioMarin Announces First Quarter 2016 Financial Results
04/25BIOMARIN PHARMA : quaterly earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

It operates its business through one segment, the biopharmaceutical development and commercialization segment.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 158 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Biopharmaceutical Development and Commercialization751.04100.1%889.90102% +18.49%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States380.0450.7%444.0850.9% +16.85%
Europe139.9418.7%178.7520.5% +27.73%
Latin America118.5615.8%142.3116.3% +20.03%
Rest of World112.4915%124.7714.3% +10.91%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé622005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA572012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD582009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Pierre LaPalme752004Director
Elaine J. Heron PhD, MBA682002Independent Non-Executive Director
Mike G. Grey632005Independent Non-Executive Director
Richard A. Meier562006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD642007Independent Non-Executive Director
Alan J. Lewis, PhD702005Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 162,292,817 161,798,724 99.7% 0 0.0% 99.7%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 17,988,101 11.1%
Fidelity Management & Research Co. 13,044,515 8.07%
Sands Capital Management LLC 11,637,466 7.20%
The Vanguard Group, Inc. 11,195,877 6.93%
T. Rowe Price Associates, Inc. 8,026,813 4.97%
PRIMECAP Management Co. 7,330,689 4.54%
BlackRock Fund Advisors 7,322,075 4.53%
Jennison Associates LLC 6,691,351 4.14%
Sabby Capital LLC 5,000,000 3.09%
JPMorgan Investment Management, Inc. 4,685,167 2.90%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.04%7,800,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
ONO PHARMACEUTICA..
OTSUKA HOLDINGS C..
BIOMARIN PHARMACE..
ASPEN PHARMACARE ..
TAISHO PHARMACEUT..
HANMI SCIENCE CO ..
-
SHANGHAI FOSUN PH..
CIPLA LTD
ENDO INTERNATIONA..
HANMIPHARM
CADILA HEALTHCARE..
HUNAN ER-KANG PHA..
SHENZHEN SALUBRIS..
DIVI'S LABORATORI..
RICHTER GEDEON VE..
JIANGSU BICON PHA..
SHENZHEN HEPALINK..
-
GLENMARK PHARMACE..
SICHUAN KELUN PHA..
-
Sector Pharmaceuticals
BioMarin Pharmaceutical In : Connections
GLyPharma Therapeutic, Inc.
Targazyme, Inc.
Itero Biopharmaceuticals LLC
DiaVacs, Inc.
Algorithme Pharma, Inc.
Zephyrus Biosciences, Inc.
Cellastra, Inc.
Amplyx Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.
Pediapharm Inc
Ziarco Group Ltd.
Reform Biologics LLC
GlycoFi, Inc.
Ziarco Pharma Ltd.
Selventa, Inc.
Sutro Biopharma, Inc.
Rapidscan Pharma Solutions, Inc.
Cytochroma, Inc.
Balance Therapeutics, Inc.
Batu Biologics, Inc.
A. M. Pappas & Associates LLC
Sosei Co. Ltd.
Biotechnology Industry Organization
Aerogen, Inc.
Capella Therapeutics, Inc.
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415-506-6700
Fax : +1 415-382-7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem